Cleared Traditional

K233920 - EOSedge

K233920 is an FDA 510(k) clearance for EOSedge, manufactured by Eos Imaging. The device is a Class 2 Radiology device with product code KPR cleared through the Traditional 510(k) pathway after a 237-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
237d
Days
Class 2
Risk

K233920 is an FDA 510(k) clearance for the EOSedge. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Eos Imaging (Paris, FR). The FDA issued a Cleared decision on August 6, 2024 after a review of 237 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Eos Imaging devices

FDA 510(k) Submission Details - K233920

510(k) Number K233920 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2023
Decision Date August 06, 2024
Days to Decision 237 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
130d slower than avg
Panel avg: 107d · This submission: 237d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KPR Device Classification - Class 2, Special Controls

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPR System, X-ray, Stationary

All 189
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K233920.
EXSYS DEXi (EXSYS DEXi-D401S-FRM)
K242847 · DRTECH Corporation · Oct 2024
Definium Pace Select ET
K242678 · Ge Hualun Medical Systems Co. , Ltd. · Oct 2024
GF85 (models GF85-3P, GF85-SP)
K242478 · Samsung Electronics Co., Ltd. · Sep 2024
EXSYS DEXi (EXSYS DEXi-D401S-FRM)
K233530 · DRTECH Corporation · Jul 2024
Radiography 7300 C
K233662 · Philips Medical Systems Dmc GmbH · Jun 2024
YSIO X.pree
K233543 · Siemens Medical Solutions · May 2024